Background. Double reading is a widely used criterion standard in breast ca
ncer screening despite a lack of evidence of the cost-effectiveness of the
second reading. This study evaluates the incremental cost-effectiveness of
such a strategy.
Design. Cost-effectiveness analysis: Nationwide population-based semi-annua
l screening program for women aged 50-59 in Finland. Participation rate was
91%. All mammograms (95,423) performed during 1990-1995 in three screening
centers of the Finnish Cancer Society were read by two radiologists with g
radings recorded. The effectiveness of the double reading was the differenc
e in cancers detected in the double compared to that of the single reading.
Incremental costs of the double reading for the health care and non-health
care and the time costs were estimated. The main outcome measure was the i
ncremental cost per additional cancer found as a result of the double-readi
ng strategy.
Results. The total number of cancers detected with the double and single re
ading were 290 and 261, respectively. A significantly higher ratio of carci
noma in situ was the causative pathology in cancers detected only by the se
cond reader. The cost per cancer detected with a single reading was US$ 18,
340. The incremental cost of any additional cancer found was US$ 25,523, th
at is, a 39% higher cost per additional cancer found by double reading.
Conclusions. The additional cost per cancer detected by double reading is n
ot drastically higher than with single reading. However, the additional cos
t per life year saved may be much higher.